[Treatment of breast cancer at the 1st Gynecology Clinic at the University of Vienna]. 1984

E Kubista, and H Salzer, and F Fischl, and G Smekal, and G Müller, and G Wagner, and E Boschitsch, and K Philipp, and J Spona, and P Aiginger

Since 1979 diagnosis, operative therapy and postoperative treatment and follow-up is performed at the Ist University-Clinic of Obstetrics and Gynecology in Vienna. This management brought a close cooperation with radiologists and other oncotherapists. A standard operation method, in our case a modified radical mastectomy with a complete dissection of the axilla after radioisotope marking of the axillary lymph nodes enables us to perform a randomised prospective study of adjuvant therapy. Though the observation time is relatively short, first results show, that metastases or local recurrences were observed only in the non-treated control group. That leads in our opinion to the cautious conclusion, that any form of adjuvant therapy is of therapeutic value. Which form of adjuvant therapy should be qualified best cannot be decided yet because of the too short follow-up period.

UI MeSH Term Description Entries
D008408 Mastectomy Surgical procedure to remove one or both breasts. Mammectomy,Mammectomies,Mastectomies
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Kubista, and H Salzer, and F Fischl, and G Smekal, and G Müller, and G Wagner, and E Boschitsch, and K Philipp, and J Spona, and P Aiginger
January 1984, Zentralblatt fur Gynakologie,
E Kubista, and H Salzer, and F Fischl, and G Smekal, and G Müller, and G Wagner, and E Boschitsch, and K Philipp, and J Spona, and P Aiginger
September 1980, Strahlentherapie,
E Kubista, and H Salzer, and F Fischl, and G Smekal, and G Müller, and G Wagner, and E Boschitsch, and K Philipp, and J Spona, and P Aiginger
January 1993, Gynakologisch-geburtshilfliche Rundschau,
E Kubista, and H Salzer, and F Fischl, and G Smekal, and G Müller, and G Wagner, and E Boschitsch, and K Philipp, and J Spona, and P Aiginger
February 1981, Onkologie,
E Kubista, and H Salzer, and F Fischl, and G Smekal, and G Müller, and G Wagner, and E Boschitsch, and K Philipp, and J Spona, and P Aiginger
January 1982, Gynakologische Rundschau,
E Kubista, and H Salzer, and F Fischl, and G Smekal, and G Müller, and G Wagner, and E Boschitsch, and K Philipp, and J Spona, and P Aiginger
June 1980, Gynakologische Rundschau,
E Kubista, and H Salzer, and F Fischl, and G Smekal, and G Müller, and G Wagner, and E Boschitsch, and K Philipp, and J Spona, and P Aiginger
September 1980, Strahlentherapie,
E Kubista, and H Salzer, and F Fischl, and G Smekal, and G Müller, and G Wagner, and E Boschitsch, and K Philipp, and J Spona, and P Aiginger
January 1987, Zeitschrift fur Geburtshilfe und Perinatologie,
E Kubista, and H Salzer, and F Fischl, and G Smekal, and G Müller, and G Wagner, and E Boschitsch, and K Philipp, and J Spona, and P Aiginger
August 1949, Wiener klinische Wochenschrift,
E Kubista, and H Salzer, and F Fischl, and G Smekal, and G Müller, and G Wagner, and E Boschitsch, and K Philipp, and J Spona, and P Aiginger
November 1947, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!